Alex Harding to chase industry dreams at CRISPR Therapeutics; Scoop: Biogen’s head of business development splits for Kite
While Alex Harding is a practicing physician, he’s long envisioned a career on the business side of drug development. Next year, he’s seizing an opportunity to further those goals at CRISPR Therapeutics.
The Swiss-American company announced on Monday that Harding — one of Endpoints News’ 20 under 40 honorees in 2020 — is joining on Jan. 5 as SVP and head of business development. CEO Samarth Kulkarni said in a news release that the appointment will be “critical in driving the next phase of growth for CRISPR.”
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters